六甘醇 | 2615-15-8

• 物质功能分类: 化学试剂 - 有机试剂 - 脂肪醇
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 六甘醇
• 中文别名: 六聚乙二醇；六乙烯二醇；六乙二醇；硫乙烯基乙二醇
• 英文名称: Hexaethylene glycol
• 英文别名: 3,6,9,12,15-pentaoxaheptadecane-1,17-diol；2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol
• CAS: 2615-15-8
• 化学式: C₁₂H₂₆O₇
• mdl: MFCD00002877
• 分子量: 282.334
• InChiKey: IIRDTKBZINWQAW-UHFFFAOYSA-N

物化性质

• 熔点：
  5-7 °C (lit.)
• 沸点：
  217 °C/4 mmHg (lit.)
• 密度：
  1.127 g/mL at 25 °C (lit.)
• 闪点：
  >110°C
• 溶解度：
  与氯仿和甲醇混溶。
• 保留指数：
  2081.8;2078
• 稳定性/保质期：

  如果按照规格正确使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  -1.9
• 重原子数：
  19
• 可旋转键数：
  16
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  86.6
• 氢给体数：
  2
• 氢受体数：
  7

安全信息

• 安全说明：
  S23,S24/25
• WGK Germany：
  2
• 危险品运输编号：
  NONH for all modes of transport
• 海关编码：
  2909499000
• RTECS号：
  MM3670000
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  密封于阴凉干燥处。

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : Hexaethylene glycol
CAS-No. : 2615-15-8
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No 1272/2008
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram none
Signal word none
Hazard statement(s) none
Precautionary statement(s) none
Supplemental Hazard none
Statements
The following percentage of the mixture consists of ingredient(s) with unknown acute toxicity: 100 %
The following percentage of the mixture consists of ingredient(s) with unknown hazards to the aquatic
environment: 100 %
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Synonyms : 3,6,9,12,15-Pentaoxaheptadecane-1,17-diol
Formula : C12H26O7
Molecular Weight : 282,33 g/mol

---

Section 4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid breathing vapors, mist or gas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Normal measures for preventive fire protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection not required. For nuisance exposures use type OV/AG (US) or type ABEK
(EU EN 14387) respirator cartridges. Use respirators and components tested and approved under
appropriate government standards such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: liquid, clear, viscous
Colour: light yellow
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 5 - 7 °C - lit.
point
f) Initial boiling point and 217 °C at 5 hPa - lit.
boiling range
g) Flash point > 113,00 °C - closed cup
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density 1,127 g/mL at 25 °C
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
LD50 Oral - rat - 32.000 mg/kg
Remarks: Behavioral:Somnolence (general depressed activity). Gastrointestinal:Other changes. Kidney,
Ureter, Bladder:Other changes.
Skin corrosion/irritation
Serious eye damage/eye irritation
Eyes - rabbit - Mild eye irritation
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
Specific target organ toxicity - single exposure
Specific target organ toxicity - repeated exposure
Aspiration hazard
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Additional Information
RTECS: MM3670000

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
Mobility in soil
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

---

Section 16. OTHER INFORMATION
Further information
Copyright 2012 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

制备方法与用途

化学反应

六甘醇由于分子结构中的氧原子存在，使其电负性大于丙酸，更易于发生化学反应。作为一种活跃的有机化学中间体，在精细化工领域有着重要的应用。

应用

六甘醇主要用于生产农药、染料、农林化学品和医药中间体等，与人们的日常生活密切相关。

合成

将36.6 g（45.0 mmol）的庚乙二醇二硬脂酸酯、150 mL的CH2Cl2和0.677 g的10%钯/碳装入带有玻璃插件的高压蒙乃尔合金弹中。在室温下以50大气压的H2进行氢解48小时后，过滤器-催化剂（可重复使用），并用 洗涤滤液。浓缩滤液得到三苯基甲烷和油的混合物。将此混合物溶解于沸腾的甲醇中，在冷却至0°C时使大部分三苯基甲烷结晶析出，然后进行过滤，并用己烷洗涤六次以去除痕量的三苯基甲烷，最终得到六甘醇。


用途

作为底物，用于通过与 CuCl(OH)-TMEDA 的分子内氧化偶合合成联萘酚基大环醚。

反应信息

• 作为反应物：
  描述：

  六甘醇 在 sodium azide 、 磷酸 、 碳酸氢钠 、 二异丙胺 、 三苯基膦 、 三氯氧磷 作用下， 以 四氢呋喃 、 甲醇 、 乙醚 、 二氯甲烷 、 水 为溶剂， 反应 70.0h， 生成 N-[9-(2-[(2'-azido-2-oxo-6,9,12,15,18-pentaoxa-3-azaicos-1-yl)(1-methylethyl)carbamoyl]phenyl)-6-(diethylamino)-3H-xanthen-3-ylidene]-N-ethylethanaminium chloride
  参考文献：
  名称：

  Fast and efficient MCR-based synthesis of clickable rhodamine tags for protein profiling

  摘要：

  蛋白质分析探针是研究蛋白质组组成的重要工具，因此对了解高等生物体内各种复杂的生物过程做出了巨大贡献。为此，应用荧光标记的活性或亲和性探针是非常理想的。特别是在活体检测低含量目标蛋白时，荧光标记的分析探针具有很高的价值，否则很难通过标准印迹技术进行分析。本文介绍了一种基于 Ugi-4 组分反应（Ugi-4-CR）的一次性合成活化荧光标签（即叠氮、炔基或 NHS）的方法。由于形成了类胨结构，产物的荧光特性对 pH 值不敏感。此外，还将以标记模型蛋白质 BSA 为例，讨论这些探针的适用性。

  DOI：

  10.1039/c1ob06581e
• 作为产物：
  描述：

  hexaethylene glycol dibenzyl ether 在 palladium on activated charcoal 氢气 作用下， 以 盐酸 、 乙醇 为溶剂， 以91%的产率得到六甘醇
  参考文献：
  名称：

  苯并氮杂鎓和苯胺阳离子套索状醚配合物的合成和性质：“鸵鸟分子”配合物和分子内侧臂-大环相互作用的证据

  摘要：

  报道了几种新型套索状醚（具有带有侧链带有侧基供体基团的大环冠聚醚）的制备。这些化合物是衍生自已知的2-羟甲基-15-冠-5或-21-冠-7的醚。侧臂包括2-氨基苯基，2，4-二氨基苯基，2-硝基苯基，2-（3'-硝基联苯）和2-（3'-氨基联苯）。在一些情况下，氨基被转化为铵盐，该铵盐通过分子内氢键显示出基本的稳定性。同样，-NH 2 +。，BF 3 -该配合物显示出分子内氢键的证据。氨基联苯残基的重氮化反应产生了一个烯二唑鎓阳离子，该阳离子经历了分子内冠状络合，这是通过红外光谱研究判断形成的，我们称之为“鸵鸟分子”复合物。将N，N-二甲基苯胺添加到分子内的芳构氮鎓阳离子络合物中可制得偶氮化合物，但euro移试剂研究清楚地表明，重氮鎓阳离子在大环之外发生了反应。

  DOI：

  10.1016/0040-4020(84)85070-x
• 作为试剂：
  描述：

  silver(I) 4-methylbenzenesulfonate 在 六甘醇 、 cesium fluoride 作用下， 以 乙腈 为溶剂， 反应 26.0h， 生成 氟甲醇4-甲基苯磺酸酯
  参考文献：
  名称：

  HPLC-free in situ¹⁸F-fluoromethylation of bioactive molecules by azidation and MTBD scavenging

  摘要：

  使用叠氮和MTBD的顺序使用，生成纯[18F]氟甲基对甲苯磺酰基，并清除未反应的去甲基前体，为18F-氟甲基化合物的无HPLC合成提供了高效策略。

  DOI：

  10.1039/c9cc04901k

文献信息

• Supramolecular gelation of alcohol and water by synthetic amphiphilic gallic acid derivatives
  作者：Hitoshi Tamiaki、Keishiro Ogawa、Keisuke Enomoto、Kazutaka Taki、Atsushi Hotta、Kazunori Toma

  DOI：10.1016/j.tet.2010.01.002

  日期：2010.2

  The supramolecular organogelation of alcohols was observed in relatively hydrophobic amphiphiles with a short oligo(ethylene glycol) unit and three long alkyl chains at room temperature, while the hydrogelation occurred in more hydrophilic gelators with a longer poly(ethylene glycol) unit and two long alkyl chains at various temperatures. When a hot aqueous solution of some of the synthetic hydrogelators

  在室温下，在具有较短的寡（乙二醇）单元和三个长烷基链的相对疏水性两亲物中观察到醇的超分子有机凝胶化，而在具有较长的聚（乙二醇）单元和两个长烷基的较亲水性胶凝剂中发生了水凝胶化。不同温度下的链条。当一些合成水凝胶器的热水溶液冷却后，在室温下形成超分子水凝胶。在室温下，在水中与分子间相互作用较少的其他两亲物中，通过升高其水性系统的温度（尤其是低于生理温度37°C），观察到了溶胶向凝胶的反相转变。
• Gold Nanoparticles Decorated with Mannose-6-phosphate Analogues
  作者：Stéphanie Combemale、Jean-Norbert Assam-Evoung、Sabrina Houaidji、Rashda Bibi、Véronique Barragan-Montero

  DOI：10.3390/molecules19011120

  日期：——

  Herein, the preparation of neoglycoconjugates bearing mannose-6-phosphate analogues is described by: (a) synthesis of a cyclic sulfate precursor to access the carbohydrate head-group by nucleophilic displacement with an appropriate nucleophile; (b) introduction of spacers on the mannose-6-phosphate analogues via Huisgen’s cycloaddition, the Julia reaction, or the thiol-ene reaction under ultrasound

  在本文中，带有 6-磷酸甘露糖类似物的新糖缀合物的制备通过以下方式进行描述：（a）通过用适当的亲核试剂亲核置换来合成环状硫酸盐前体以接近碳水化合物头基；（ b ）通过Huisgen的环加成反应、Julia反应或超声活化下的硫醇-烯反应在6-磷酸甘露糖类似物上引入间隔基。有了所得到的化合物，金纳米粒子可以用各种碳水化合物衍生物（糖缀合物）进行功能化，然后测试血管生成活性。据观察，将糖类似物与纳米颗粒分开的间隔物的长度和柔韧性对生物反应几乎没有影响。
• Synthesis of peptide homo‐ and heterodimers as potential mimics of platelet‐derived growth factor BB
  作者：Louise A. Stubbing、Harveen Kaur、Sheryl X. Feng、Miranda Aalderink、Michael Dragunow、Margaret A. Brimble

  DOI：10.1002/pep2.24150

  日期：2020.7

  disease. The platelet‐derived growth factor receptor β (PDGFRβ)/platelet‐derived growth factor BB (PDGF‐BB) signalling pathway is key to the regulation of pericyte survival and proliferation. A series of peptide dimers mimicking the ligand PDGF‐BB were prepared in the hope of stimulating PDGFRβ internalisation and activation of this pathway. Copper‐catalysed azide‐alkyne cycloaddition of peptide monomers

  在诸如阿尔茨海默氏病等神经系统疾病中，周细胞的丢失与血脑屏障的泄漏有关。血小板衍生的生长因子受体（PDGFRβ）/血小板衍生的生长因子BB（PDGF-BB）信号通路是调节周细胞存活和增殖的关键。制备了一系列模拟配体PDGF-BB的肽二聚体，以期刺激PDGFRβ的内在化和该途径的激活。铜催化的叠氮基-炔烃环化肽单体与不同长度的PEG化接头的加成反应提供了所需的肽二聚体。在人脑周细胞测定中对肽二聚体的评估显示，浓度小于10μM时，对PDGFRβ的内在化和细胞增殖均无影响。浓度<10μM时，肽二聚体也不能作为PDGFRβ的拮抗剂。
• [EN] BCR-ABL TYROSINE-KINASE LIGANDS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME<br/>[FR] LIGANDS DE TYROSINE-KINASE BCR-ABL CAPABLES DE SE DIMÉRISER DANS UNE SOLUTION AQUEUSE, ET PROCÉDÉS D'UTILISATION DE CEUX-CI
  申请人：COFERON INC

  公开号：WO2015106292A1

  公开（公告）日：2015-07-16

  Described herein are monomers capable of forming a biologically useful multimer when in contact with one, two, three or more other monomers in an aqueous media. In one aspect, such monomers may be capable of binding to another monomer in an aqueous media (e.g. invivo) to form a multimer (e.g. a dimer). Contemplated monomers may include a ligand moiety, a linker element, and a connector element that joins the ligand moiety and the linker element. In an aqueous media, such contemplated monomers may join together via each linker element and may thus be capable of modulating one or more biomolecules substantially simultaneously, e.g., modulate two or more binding sites on a Bcr-Abl tyrosine kinase.

  本文描述了一种单体，当与水性介质中的另一个、两个、三个或更多其他单体接触时，能够形成生物学上有用的多聚体。在一个方面，这种单体可能能够在水性介质（例如体内）中与另一个单体结合以形成多聚体（例如二聚体）。考虑到的单体可能包括配体基团、连接元素和连接配体基团与连接元素的连接元素。在水性介质中，这些考虑到的单体可以通过每个连接元素结合在一起，因此可以同时调节一个或多个生物分子，例如，调节Bcr-Abl酪氨酸激酶上的两个或更多结合位点。
• Mono- and dicationic short PEG and methylene dioxyalkylglycerols for use in synthetic gene delivery systems
  作者：Christopher A. Hurley、John B. Wong、Jimmy Ho、Michele Writer、Scott A. Irvine、M. Jayne Lawrence、Stephen L. Hart、Alethea B. Tabor、Helen C. Hailes

  DOI：10.1039/b719702k

  日期：——

  A range of monocationic and dicationic dioxyalkylglycerol cytofectins have been synthesised possessing methylene and short n-ethylene glycol spacers. The monocationic compounds were found to be effective in transfections when formulated as lipopolyplexes with peptide and DNA components, in particular with shorter PEG head groups which may have less effect on peptide targeting in the ternary complex.

  一系列单阳离子和双阳离子二氧烷基甘油细胞转染剂已被合成出来，它们具有亚甲基和短的正乙烯二醇间隔基。单阳离子化合物在与多肽和DNA成分组成的脂质复合物配方中被发现具有有效的转染效果，尤其是带有较短PEG头部基团的化合物，这些头部基团可能在三元复合物中对多肽的靶向性影响较小。

表征谱图